Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen, UCB halt testing of drug for fracture healing, but continue testing for osteoporosis
Amgen, UCB halt testing of drug for fracture healing, but continue testing for osteoporosis
Amgen, UCB halt testing of drug for fracture healing, but continue testing for osteoporosis
Submitted by
admin
on February 12, 2013 - 10:55am
Source:
Yahoo/AP
News Tags:
Amgen
UCB Pharmaceuticals
fractures
osteoporosis
romosozumab
Headline:
Amgen, UCB halt testing of drug for fracture healing, but continue testing for osteoporosis
Do Not Allow Advertisers to Use My Personal information
